The U.S. Army Medical Research and Development Command selected Philips, Aurora-based University of Colorado and BioIntellisense for the clinical study, which will comprise 2,500 eligible participants who have a recently known COVID-19 exposure and/or are experiencing early symptoms, according to the Dec. 22 news release.
University of Colorado’s medical school will help test BioIntellisense’s wearable device, which monitors the user’s heart rate, respiratory rate and temperature. With the collaboration, the organizations aim to advance the use of wearable diagnostics to help with early identification and containing presymptomatic COVID-19 cases.
More articles on digital transformation:
Top 5 digital transformation stories of 2020
Los Angeles offers residents COVID-19 digital vaccine records stored in Apple, Google apps
11 recent big tech partnerships in healthcare: Amazon, Apple, Google & more
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
